Polymorphisms in the dopamine D4 receptor gene and attention-deficit hyperactivity disorder

NeuroReport

Volumn 14, Issue 11, 2003, Pages 1463-1466

  Mill, Jonathan ^a   Fisher, Naomi ^a   Curran, Sarah ^a   Richards, Sandra ^a   Taylor, Eric ^a   Asherson, Philip ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Association study; Attention deficit hyperactivity disorder (ADHD); DRD4; Genetics; Haplotypes; Linkage disequilibrium; Promoter

Indexed keywords

CYTOSINE; DOPAMINE; DOPAMINE 4 RECEPTOR; GUANINE; POLYGUANYLIC ACID; THYMINE;

ARTICLE; ATTENTION DEFICIT DISORDER; EXON; FAMILY; GENE DUPLICATION; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HAPLOTYPE; HUMAN; INTRON; MAJOR CLINICAL STUDY; NUCLEIC ACID BASE SUBSTITUTION; PRIORITY JOURNAL; PROMOTER REGION;

ALLELES; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CHILD; CHROMOSOMES; DNA; FEMALE; GENE DUPLICATION; GENETIC MARKERS; GENOTYPE; HAPLOTYPES; HUMANS; LINKAGE (GENETICS); MALE; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS); RECEPTORS, DOPAMINE D2; RECEPTORS, DOPAMINE D4;

EID: 0042833181     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001756-200308060-00011     Document Type: Article

References (19)

1. Swanson JM, Sergeant JA, Taylor E et al. Lancet 351, 429-433 (1998).
2. Faraone SV and Biederman J. Biol Psychiatry 44, 951-958 (1998).
3. DiMaio S, Grizenko N and Joober R. J Psychiatry Neurosci 28, 27-38 (2003).
4. Van Tol HH, Bunzow JR, Guan HC et al. Nature 350, 610-614 (1991).
5. Van Tol HH, Wu CM, Guan HC et al. Nature 358, 149-152 (1992).
6. Asghari V, Sanyal S, Buchwaldt S et al. J Neurochem 65, 1157-1165 (1995).
7. Faraone SV, Doyle AE, Mick E and Biederman J. Am J Psychiatry 158, 1052-1057 (2001).
8. Mill JS, Caspi A, McClay J et al. Mol Psychiatry 7, 383-391 (2002).
9. Okuyama Y, Ishiguro H, Nankai M et al. Mol Psychiatry 5, 64-69 (2000).
10. McCracken JT, Smalley SL, McGough JJ et al. Mol Psychiatry 5, 531-536 (2000).
11. Barr CL, Feng Y, Wigg KG et al. Am J Med Genet 105, 84-90 (2001).
12. Petronis A, O'Hara K, Barr CL et al. Hum Genet 93, 719 (1994).
13. Mill J, Curran S, Kent L et al. Mol Psychiatry 6, 440-444 (2001).
14. Freeman B, Smith N, Curtis C et al. Behav Genet 33, 67-72 (2003).
15. Seaman MI, Fisher JB, Chang F and Kidd KK. Am J Med Genet 88, 705-709 (1999).
16. Jovanovic V, Guan HC and Van Tol HH. Pharmacogenetics 9, 561-568 (1999).
17. Kazmi MA, Snyder LA, Cypess AM et al. Biochemistry 39, 3734-3744 (2000).
18. Watts VJ, Vu MN, Wiens BL et al. Psychopharmacology (Berl) 141, 83-92 (1999).
19. D'Souza U, Russ C, Tahir E et al. Am J Med Genet 114, 880 (2002).